318 related articles for article (PubMed ID: 18331381)
1. Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability.
Ezuki S; Kanno T; Ohto H; Herschel L; Ito T; Kawabata K; Seino O; Ikeda K; Nollet KE
Vox Sang; 2008 May; 94(4):292-8. PubMed ID: 18331381
[TBL] [Abstract][Full Text] [Related]
2. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
van der Meer PF; Vrielink H; Pietersz RN
Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
[TBL] [Abstract][Full Text] [Related]
3. Improved extension of platelet storage in a polyolefin container with higher oxygen permeability.
Yuasa T; Ohto H; Yasunaga R; Kai T; Shirahama N; Ogata T
Br J Haematol; 2004 Jul; 126(1):153-9. PubMed ID: 15198746
[TBL] [Abstract][Full Text] [Related]
4. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
5. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
7. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
8. [Properties of stored platelet concentrates: effect of the suspension media and type of pouch used].
Castrillo A; Castro A; Cid J; Adelantado M; Eiras A; Flores J; Solla E; Varela J; García-Villaescusa R
Sangre (Barc); 1999 Oct; 44(5):315-8. PubMed ID: 10618906
[TBL] [Abstract][Full Text] [Related]
9. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
11. A novel second-generation polyolefin container for storage of single-donor apheresis platelets.
Shimizu T; Kouketsu K; Kamiya T; Futagawa H; Hirose S
Vox Sang; 1989; 56(3):174-80. PubMed ID: 2499120
[TBL] [Abstract][Full Text] [Related]
12. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
13. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
15. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.
Heddle NM; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Blajchman MA; Kelton JG
Transfusion; 2005 Jun; 45(6):904-10. PubMed ID: 15934988
[TBL] [Abstract][Full Text] [Related]
18. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
[TBL] [Abstract][Full Text] [Related]
19. Seven-day storage of single donor platelets in polyolefin bags: clinical, biochemical, morphological and microbiological evaluation.
Dragani A; Iacone A; Angelini A; D'Antonio D; Accorsi P; Fioritoni G; Geraci L; Berardi A; Quaglietta A; Di Bartolomeo P
Int J Artif Organs; 1988 Jan; 11(1):51-6. PubMed ID: 3360514
[TBL] [Abstract][Full Text] [Related]
20. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
